American Society of Hirudotherapy

Ministry of Health and Medical Services — Solomon Islands

Solomon Islands MHMS · Solomon Islands · oceania

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Solomon Islands' MHMS — leech-specific authorisation pathway not independently verified by ASH.

Regulatory Profile

Agency type
national regulator
Region
oceania
Country
Solomon Islands
Leech status
unregulated
Last ASH review
2026-05-28

Relevant Regulation Codes

  • Solomon Islands Pharmacy and Poisons Act Cap. 109 and amendments
  • Pacific Island Countries (PIC) joint procurement arrangements through the Pacific Pharmaceutical Procurement Service where applicable

Prescriber Requirements

  • Solomon Islands Medical Board–registered physician — order required for any biomedical device application
  • Allied health professional application under physician supervision per institutional protocol

Supply Chain & GMP

Solomon Islands MHMS registration as applicable; English and Solomon Islands Pijin-language labelling per local convention. Standard cold-chain conditions, with logistical constraints typical of Melanesian archipelago distribution.

Import/Export Rules

Solomon Islands MHMS and Biosecurity Solomon Islands clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.

Reimbursement Context

Solomon Islands' public health system coverage depends on inpatient bundling; outpatient hirudotherapy is generally not separately reimbursed.

ASH Editorial Notes

Leech-specific authorisation pathway not independently verified by ASH; falls under general medical-device / traditional-medicine framework as appropriate. Pacific island nations frequently rely on Australian TGA, New Zealand Medsafe and WHO-prequalified products via Pacific cooperation arrangements.

Related Jurisdictions

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.